IP-Fälle und Artikel
Inventive step at the UPC: Court of Appeal sets definitive test
10 Dezember 2025
The Court of Appeal has adopted a holistic assessment of inventive step and has moved away from the EPO’s problem…
UPC Court of Appeal reverses First Instance decision: Amgen’s patent ruled valid
10 Dezember 2025
The Unified Patent Court (UPC) Court of Appeal has overturned the order of the Munich Central Division and ruled that…
UPC: fee increases effective 01 January 2026
10 Dezember 2025
Unified Patent Court (UPC) fee amendments will enter into force on 01 January 2026. The amendments will apply to all…
First UPC injunction covering the UK: Fujifilm v Kodak
31 Oktober 2025
In Fujifilm v Kodak (UPC_CFI_365/2023) the Mannheim Local Division of the Unified Patent Court (UPC) granted a permanent injunction covering…
Permissibility of new arguments and facts during proceedings: comparing EPO and UPC practice
31 Oktober 2025
For patentees and opponents alike, the ability to put forward new arguments is a valuable element of any opposition or…
Temporal limitations of the UPC: XSYS v Esko
31 Oktober 2025
The Unified Patent Court (UPC) Court of Appeal has answered questions relating to its jurisdiction before entry into force of…
UPC procedural case law: stays of proceedings
31 Oktober 2025
As part of our ongoing series discussing the burgeoning procedural case law of the Unified Patent Court (UPC), we take…
Infringement proceedings: conflicting EPO & UPC outcomes
31 Oktober 2025
On 21 July 2025 the UPC released its decision (ORD_598566/2023) on the long-running Edwards Lifesciences Corporation v Meril Life Sciences…
Added matter at the UPC: Samsung succeeds in revocation of Headwater patents
06 Oktober 2025
Samsung has emerged triumphant in revocation counterclaims against Headwater’s patents EP3110069 and EP2391947 at the UPC’s Düsseldorf and Munich Local…
Don’t jump the gun: preliminary injunction granted in 17 UPC states against generic pharmaceutical company
24 September 2025
In a recent order, the UPC Court of Appeal granted Boehringer Ingelheim provisional measures against generics company, Zentiva, for its…
UPC CFI 315/2023, GRUR-RS 2024, 30221: NJOY Netherlands/Juul Labs International
18 September 2025
The decision rendered by the Paris Central Division on 05 November 2024 in the revocation proceedings between NJOY Netherlands and…
Seite 1 von 15
Weiter